Bengt Hallengren
1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Long-Term Outcome of Graves’ Disease : A Gender Perspective
(
- Contribution to journal › Article
-
Mark
Fracture incidence in Graves' disease : A population-based study
(
- Contribution to journal › Article
-
Mark
Autoimmunity in sarcoidosis : the tip of the Iceberg
(
- Contribution to journal › Letter
- 2022
-
Mark
Multiple etiologies explain the association between sarcoidosis and diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Long term outcome after toxic nodular goitre
(
- Contribution to journal › Article
- 2021
-
Mark
Treatment of patients with Graves’ disease in Sweden compared to international surveys of an ‘index patient’
(
- Contribution to journal › Article
- 2019
-
Mark
Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism : A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey
(
- Contribution to journal › Article
- 2016
-
Mark
Adjuvant Treatment of Graves' Disease with Diclofenac : Safety, Effects on Ophthalmopathy and Antibody Concentrations
(
- Contribution to journal › Article
- 2015
-
Mark
Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.
(
- Contribution to journal › Article
- 2014
-
Mark
ASSOCIATION OF BTG2, CYR61, ZFP36, AND SCD GENE POLYMORPHISMS WITH GRAVES' DISEASE AND OPHTHALMOPATHY.
(
- Contribution to journal › Article